Fig. 11

(A): Forest plot of the impact of SRC core targets on the prognosis of malignant tumor diseases. (B): Forest plot of the impact of CASP3 core targets on the prognosis of malignant tumor diseases. (C): Forest plot of the impact of ERBB2 core targets on the prognosis of malignant tumor diseases. (D): Forest plot of the impact of PTGS2 core targets on the prognosis of malignant tumor diseases. (E): Forest plot of the impact of MTOR core targets on the prognosis of malignant tumor diseases. (F): Forest plot of the impact of MAPK14 core targets on the prognosis of malignant tumor diseases. (G): Forest plot of the impact of CDK1 core targets on the prognosis of malignant tumor diseases. (H): Forest plot of the impact of ABL1 core target on the prognosis of testicular cancer disease. (I): Forest map of the impact of MAPK8 core targets on the prognosis of prostate cancer diseases. (J-L): Forest map of the effects of ESR1, BCL2 and FOS core targets on the prognosis of esophageal cancer.